Editors' ChoiceCancer

Loss of TET2 boosts cell fitness

See allHide authors and affiliations

Science Translational Medicine  22 Jul 2020:
Vol. 12, Issue 553, eabd3619
DOI: 10.1126/scitranslmed.abd3619


The loss of TET2 favors a pathogenic switch to a stem cell–like state in cancer.

View Full Text

Stay Connected to Science Translational Medicine